Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWater Intel. Regulatory News (WATR)

Share Price Information for Water Intel. (WATR)

Share Price is delayed by 15 minutes
Get Live Data
247.50    -4.00 (-1.64%)
Bid:
240.00
Ask:
255.00
Spread: 15.00 (6.25%)
Market Cap: £40.41m
WATR Live PriceLast checked at - London Stock Exchange

Intraday Water Intel. Share Chart

Management Changes

8 Oct 2008 07:00

RNS Number : 3184F
Qonnectis plc
08 October 2008
 

Qonnectis plc ("Qonnectis" or the "Company")

Management Changes

Due to the current ill health of Chief Executive Michael Tapia the Board announces that Guy Chant, currently a Non Executive Director of the Company will act as interim Chief Executive with immediate effect during this period.

Guy has had extensive experience within the European utilities industry, at both senior management and Board levels. Between 1994 and 1999 he was Managing Director of Thames Municipal Products Ltd ("TMP"). Between 2000 and 2004 he was Commercial Director of Thames Water Utilities Ltd and External Affairs Director of Thames Water plc. More recently, Guy was Executive Director at Berlinwasser Holding AG (a joint venture between Land Berlin, RWE/Thames Water ("RWE") and Veolia Environnement S.A.), the main water utility serving the city of Berlin.

The Board is pleased to announce that Barbara Spurrier has been appointed finance director with immediate effect.

Barbara is a qualified certified accountant with over 25 years experience in financial and accountancy roles. She is a founder and Director of Cambridge Equity Partners Ltd., a consultancy business focussing on corporate finance projects, where she has worked with numerous companies to develop strategic business plans and objectives. Barbara has experience in assisting companies to secure capital from institutions and private investors in order to facilitate expansion and development, and has undertaken full business reviews to identify and provide action on key issues.

As previously announced the Company expects to release its preliminary announcement of the results for the year ended 30 June 2008, in November 2008.

Enquiries:

Qonnectis plc 01932 788299 

Guy Chant

Barbara Spurrier

Finncap 0207 600 1658

Clive Carver

Appendix

In accordance with Schedule Two, paragraph (g) of the AIM Rules for Companies, the following information in relation to the appointment of Barbara Spurrier to the Board is disclosed:

Full name: Barbara Joyce Spurrier

Previous names: Barbara Joyce Huxley-Parlour

Barbara Joyce Gagg

Age: 52

Barbara Spurrier currently holds or has held the following directorships and partnerships in the last five years.

Current Directorships and Partnerships

Directorships held in the last five years

Cambridge Equity Partners Ltd.

CBIOS Ltd.

Cambridge Financial Partners LLP

Cellexus Biosystems Inc. 

Cellexus Biosystems Plc.

DCM Incontrol Ltd.

Fair 2 U Ltd.

Freshbourne Ltd 

OxLoc Ltd.

Renewable Energy fuels Worldwide Ltd.

Rototek Ltd

SG32 Ltd

Stribbons Ltd.

TDLP Associates Ltd.

Barbara Spurrier has been a director of the following:

Cellexus Biosystems Plc which was put into administrative receivership on 3 March 2008.

Strathcarron Sports Cars plc which was put into voluntary creditors liquidation on 21 November 2001 with an estimated deficiency as regards creditors of £2,633,000.

J. A. Gagg & Sons Limited which became insolvent under receivership rule 3.32 and was dissolved on 18 November 1997.

There are no further disclosures to be made in relation to Barbara Spurrier pursuant to Schedule Two, paragraph (g) of the AIM Rules for Companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUBUNRWRRRRAA
Date   Source Headline
29th Sep 20257:00 amRNSInterim Results
1st Sep 20259:47 amRNSTotal Voting Rights
27th Aug 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
26th Aug 20257:20 amRNSTransaction in Own Shares & Total Voting Rights
22nd Aug 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
20th Aug 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
19th Aug 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
8th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
6th Aug 20257:00 amRNSFranchise Reacquisition & Investor Conference
31st Jul 20255:10 pmRNSTotal Voting Rights
23rd Jul 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
22nd Jul 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
21st Jul 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
17th Jul 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
16th Jul 20257:01 amRNSTransaction in Own Shares & Total Voting Rights
16th Jul 20257:00 amRNSAppointment of Joint Broker
30th Jun 202512:00 pmRNSAudited Results for Year Ended 31 December 2024
30th May 202512:00 pmRNSTotal Voting Rights
28th May 202510:49 amRNSTransaction in Own Shares and Total Voting Rights
23rd May 20258:00 amRNSTransaction in Own Shares & Total Voting Rights
22nd May 20257:00 amRNSQ1 Trading Update
9th May 20253:35 pmRNSHolding(s) in Company
30th Apr 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
10th Apr 20257:30 amRNSTransaction in Own Shares & Total Voting Rights
1st Apr 20257:00 amRNSTotal Voting Rights
14th Mar 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
13th Mar 202510:15 amRNSTransaction in Own Shares & Total Voting Rights
3rd Mar 20257:00 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
27th Feb 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
26th Feb 20257:00 amRNSStrategic Partnership with StreamLabs, Inc.
26th Feb 20257:00 amRNS2024 Trading Update, Acquisitions & Strategic Plan
17th Feb 20257:00 amRNSNotice of 2024 Trading Update and Strategic Plan
7th Feb 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
6th Feb 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
2nd Jan 20252:31 pmRNSTotal Voting Rights
2nd Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Dec 20247:00 amRNSNine Months Trading & Capital Allocation Update
29th Nov 20244:45 pmRNSTotal Voting Rights
27th Nov 20247:43 amRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20247:00 amRNSTransaction in Own Shares & Total Voting Rights
14th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSStrategic Reacquisition of Dallas, Texas Franchise
31st Oct 20247:00 amRNSTotal Voting Rights
18th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Oct 20247:00 amRNSResult of AGM
25th Sep 20247:00 amRNSInterim Results
16th Sep 20247:00 amRNSNotice of AGM, Rule 9 Waiver & Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.